From Collection to Infusion: Comprehensive CAR T Treatment and Management Strategies From CAR T Specialists The Real-World Logistics of CAR T Therapy: Financial and Practical Considerations Clinical Data Supporting CAR T in Earlier Lines: Updates From the CARTITUDE...
During a recent OncLive Peer Exchange®, a panel of expert oncologists in multiple myeloma highlighted updated findings from clinical trials primarily presented during the 65th American Society of Hematology Annual Meeting & Exposition (2023 ASH Annual Meeting), which took place in December 202...
21. Brown PA, Ji L, Xu X, et al. Effect of postreinduction therapy consolidation with blinatumomab vs chemotherapy on disease-free survival in children, adolescents, and young adults with first relapse of B-cell acute lymphobla...
Choosing Wisely is a medical stewardship and quality-improvement initiative led by the American Board of Internal Medicine (ABIM) Foundation in collaboration with national medical specialty societies as well as organizations that represent other members of the clinical care team. Participating societies wer...
Forward-looking statements include, but are not limited to, the expected presentation of clinical data for uproleselan, and any other statement containing terminology such as “may,”“will,”“should,”“expects,”“plans,”“anticipates,”“believes,”“estimates,”“predicts,”...
Clinical outcomes of subsequent therapies in patients with RRMM following talquetamab treatment: analyses from the Phase 1/2 MonumenTAL-1 study Abstract #3377 Updated results of talquetamab, a GPRC5D x CD3 bispecific antibody, in...
anticipated timing of patient enrollment in the HPN217 Phase 1 trial; the association of interim clinical data and preclinical results with potential treatment outcomes; the possibility and timing of AbbVie’s option to license HPN217 and ...
(2018). Eco-friendly treatment strategies for wastewater containing dyes and heavy metals. In: Gupta, T., Agarwal, A. K., Agarwal, R. A., Labhsetwar, N. K. (eds) Environmental Contaminants: Measurement, Modelling and Control. Springer Singapore, Singapore, pp 317–360. https://doi.org...
Monitor complete blood counts regularly during treatment. Interrupt treatment, reduce the dose, or discontinue treatment as warranted. Second Primary Malignancies Second primary malignancies, including skin cancers and other solid tumors, occurred in 12% of 1029 p...
Intracranial Hemorrhage — Serious intracranial hemorrhage (ICH) may occur with AYVAKIT treatment; fatal events occurred in <1% of patients. Overall, ICH (eg, subdural hematoma, ICH, and cerebral hemorrhage) occurred in ...